Immunosuppressive therapy for pharmacoresistant epilepsy due to primary antiphospholipid syndrome. - Falip, M; Miró, J; Jaraba, S; Cusó, S; Capdevila, O; Graus, F; Martínez-Yélamos, A (Scandinavian Journal of Rheumatology, 2015)